Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Bridgebio Pharma Inc
About BBIO
BridgeBio Pharma, Inc. is a biopharmaceutical company. It discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases. Its pipeline of development programs ranges from early science to advanced clinical trials, which includes Attruby, an oral small molecule near-complete transthyretin (TTR) stabilizer, for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); Beyonttra for the treatment of TTR Amyloidosis; Low-dose Infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor (TKI) for the treatment of children with achondroplasia and hypochondroplasia; Encaleret, an oral small molecule antagonist of the calcium sensing receptor (CaSR) that it is developing for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418, for the treatment of Limb Girdle Muscular Dystrophy Type 2I. It also conducting a Phase 1/2 study (CANaspire) for BBP-812 for Canavan disease.
Find out what a historical investment in Bridgebio Pharma Inc would be worth today using our BBIO stock calculator.
Market Capitalisation
$13.77B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
928.88K
High today
$71.74
Low today
$69.03
Open price
$70.56
52-week high
$84.94
52-week low
$31.77
Ready to start your investing journey with Stake?
Open an accountHow do I buy BBIO shares in Australia?
Buying BBIO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Bridgebio Pharma Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BBIO
What is the ticker symbol of Bridgebio Pharma Inc?
The ticker symbol for Bridgebio Pharma Inc is BBIO.
How much is one share of BBIO?
One share of BBIO is valued at $69.23 as of 22 May 2026.
What is the market capitalisation of Bridgebio Pharma Inc BBIO?
As of 22 May 2026 Bridgebio Pharma Inc has a market cap of $13.77B.
What is the 52-week high for Bridgebio Pharma Inc stock?
The Bridgebio Pharma Inc 52-week high stock price is $84.94.
What is the 52-week low for Bridgebio Pharma Inc stock?
The Bridgebio Pharma Inc 52-week low stock price is $31.77.
Can I buy BBIO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BBIO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BBIO on Stake
- Buy BBIO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BBIO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BBIO related stocks